Last update: 29/01/2019, Dr. Miguel B. Royo Salvador, Medical Board number 10389. Neurosurgeon y Neurologist.
Idiopathic Syringomyelia is defined by the presence of an intramedullary cyst filled with clear fluid, within the spinal cord. Symptoms of generalized deterioration of the spinal cord (predominantly related to thermal sensitivity) are characteristic.
Figure 1.- Image showing the interstitial fluid or serum that fills the intramedullary cyst.
This is the result of the nervous tissue death, caused by the ischemia-oedema
produced by the traction from the filum terminale.
Described by: Estienne in 1546 in “La disection du corps humain”.
Named by: the anatomist Charles Prosper Ollivier d’Angers (1796–1845) in Paris in 1824, and published in his “Traité de la moelle epinière et ses maladies”.
Incidence: 84 cases per million people. According to the Filum System® criteria, the incidence is much higher.
The most frequent symptoms of idiopathic syringomyelia in our patients (from more to less recurrent) are: pain in extremities, neck ache, thermal and pain sensitivity alterations, lower back pain, upper back pain, headache, gait alterations, paresis, sphincter alterations.
A. Primary or idiopathic Syringomyelia. Idiopathic Syringomyelia is a fluid-filled intramedullary cyst. The cause of its formation is unknown.
B. Secondary Syringomyelia. Secondary Syringomyelia is an intramedullary cyst filled with interstitial fluid or serum, the cause of which is tumorous, traumatic, infectious or other. Its cause could produce a necrosis of the spinal cord parenchyma, exerting an invasive effect by compression, traction or a combination of the 3 mechanisms.
– Conventional theories:
– The Cord Traction Theory according to the Filum Filum System®:
Dr. Miguel B. Royo-Salvador’s theory considers the syringomyelic cavitation as the result of nervous tissue necrosis, caused by the ischemia-oedema produced by the traction from an overly tense film terminale (not detectable on imaging). The syringomyelic cavitation is filled with interstitial fluid or serum. During its evolution, it can fistulize into the perimedullary space or the ependymal canal and exchange interstitial fluid with cerebrospinal fluid.
– Filum Disease:
Dr. Royo-Salvador, with his research and doctoral thesis (1992), proved the theory that considers several diseases of unknown cause (Arnold-Chiari Syndrome Type I, idiopathic Syringomyelia, idiopathic Scoliosis, platybasia, basilar invagination, odontoid retroflexion, brain stem kinking, and others) as part of a new disease concept (the Filum Disease) and that they share a common cause (spinal cord and entire nervous system traction).
The traction force of the entire nervous system in the Filum Disease occurs in all human embryos, hence they all suffer its consequences to a greater or lesser extent, and the consequences manifest in many different ways and intensities.
Other diseases, such as herniated discs, some cerebral vascular insufficiency syndromes, facet joint and Baastrup syndromes, fibromyalgia, chronic fatigue, nocturnal enuresis, urinary incontinence and pronounced paraparesis, are related, due to their cause, to the Filum Disease.
A health method, the Filum System®, has been designed to specify the diagnosis, provide guidance for the treatment and follow-up of the Filum Disease.
The most influential risk factors for the development of Idiopathic Syringomyelia are the following:
Complications of Idiopathic Syringomyelia in the Filum Disease may depend on the involvement of the spinal cord and blood flow within it, due to the caudal traction. This can cause the deterioration of mainly motor and sensitive functions, which can lead to severe complications for the patient:
The conventionally accepted treatment for Idiopathic Syringomyelia is neurosurgical.
Currently, the ventriculoperitoneal shunting or arachnolysis is the standard treatment performed in most centres worldwide for this diagnosis. Usually this indication is especially for severely symptomatic cases, as it causes more morbidity and mortality than the natural evolution of the condition itself.
The syringomyelic cavitation shunting does not eliminate the cause of the disease. It is applied to treat one of the consequences or sequelae – the accumulation of fluid – by perforating the already damaged spinal cord. For this reason we consider this surgery to be contraindicated.
Since 1993, however, with the publication of Dr Royo-Salvador’s doctoral thesis, which links the caudal traction of the entire nervous system due to the filum terminale to being the cause of the syringomyelic cavitation – among other diseases -, a new treatment has been designed. It is in this case etiological (cause-related) since the caudal cord traction force responsible for the pathological mechanism is eliminated by surgically sectioning the filum terminale.
The sectioning of the Filum Terminale with minimally invasive technique is one of the protocolized surgeries within the Filum System® health method.
It usually is indicated as soon as possible in all cases, from mildly to severely symptomatic, as its risks are minimal, much lower than those of the condition itself, and it also stops the condition’s progression.
1. Eliminates the cause of Idiopathic Syringomyelia and several associated conditions (Arnold-Chiari Syndrome Type I, Scoliosis, Platybasia, Basilar invagination, odontoid retroflexion, brain stem kinking and possibly nocturnal enuresis).
2. Eliminates the risk of sudden death.
3. Its application in over 1500 cases involved a mortality rate of 0%, with no sequelae.
4. The surgical time with the minimally invasive technique is of 45 minutes. Few hours of hospitalisation. Local anaesthesia. Short post-operative period without limitations.
5. Improves the symptoms and stops the progression in cases of Arnold-Chiari Syndrome Type I, Syringomyelia and Scoliosis of less than 40 degrees.
6. Prevents hydrocephalus that could ensue because of the impact of the cerebellar tonsils.
7. Improves blood circulation throughout the Nervous System, hence the cognitive faculties that can be affected by the cord traction.
1. Minimal injury in the sacrum region.
2. The improvement of spasticity is sometimes wrongly interpreted as a lessening of strength.
3. The improvement of altered tactile and pain reception sensitivity can wrongly be perceived as an inconvenience.
4. As the blood flow to the brain increases, so does brain activity and mood swings can be observed in the early post-operative period.
1. Few patients improve.
1. It does not eliminate the cause.
2. A mortality rate of up to 3% in cerebrospinal fluid diversion surgeries (shunting).
3. 47% of severe complications (spinal cord lesions, infections, obstructions or haemorrhages).
4. 53% of cases with shunts need to be reoperated.
5. 17% of cases with arachnolysis need to be reoperated.
1. Post-operative aseptic meningitis.
2. Post-operative neurological deficit.
3. Catheter displacement.
5. Post-operative sensitive deficit.
6. Sphincter alterations.
7. Catheter obstruction.
9. Post-operative apnoea.
10. Intramedullary haematoma.
11. Intramedullary abscess.
12. Post-operative tethering.
15. Urinary infection.
17. Intracranial hypotension syndrome.
More than 1.500 idiopathic Syringomyelia patients, with or without idiopathic Scoliosis and/or Arnold-Chiari Syndrome type I, have already undergone surgery according to the Filum System® method.
The purpose of the surgical procedure is to stop the evolution of the disease and to prevent the intramedullary cysts and the lesions from increasing further. Nevertheless, in some cases remarkable improvements of the clinical status have been achieved, even including a reabsorption of the fluid followed by a collapse of the cavitation.
Our English Department is at your disposal to help you with your enquiries.
All consultations received through this form or through the different email addresses of the 'Institut Chiari & Siringomielia & Escoliosis de Barcelona' are derived to the medical team to be studied and are supervised by Dr. Miguel B. Royo Salvador.
* It is imperative to tick this box.
The Institut Chiari & Siringomielia & Escoliosis de Barcelona (ICSEB) complies with the established in EU regulation 2016/679 (GDPR).
The contents of this website are a non-official translation of the original content of the website in Spanish. The translation is courtesy of the Institut Chiari & Siringomielia & Escoliosis de Barcelona with the purpose of facilitating comprehension for anyone who wishes to Access the website.